MEDINDIA
English
हिन्दी
Español
français
中文
Email
Abciximab
Meclofenamic acid may increase the anticoagulant activities of Abciximab.
Acebutolol
Meclofenamic acid may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Acemetacin.
Acenocoumarol
Meclofenamic acid may increase the anticoagulant activities of Acenocoumarol.
Acetaminophen
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Acetaminophen.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Meclofenamic acid.
Alclometasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alendronic acid.
Aliskiren
Meclofenamic acid may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Meclofenamic acid.
Alprenolol
Meclofenamic acid may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Meclofenamic acid.
Amcinonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Amcinonide.
Amikacin
Meclofenamic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Meclofenamic acid may decrease the antihypertensive activities of Amiloride.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Aminosalicylic Acid.
Amiodarone
Meclofenamic acid may decrease the antihypertensive activities of Amiodarone.
Ancrod
Meclofenamic acid may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Androstenedione.
Anhydrous Tacrolimus
Meclofenamic acid may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Antipyrine.
Antithrombin III
Meclofenamic acid may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Meclofenamic acid may increase the anticoagulant activities of Antithrombin III human.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Meclofenamic acid.
Apixaban
Meclofenamic acid may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Meclofenamic acid.
Arbekacin
Meclofenamic acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Meclofenamic acid may increase the anticoagulant activities of Ardeparin.
Argatroban
Meclofenamic acid may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Meclofenamic acid may increase the anticoagulant activities of Argatroban.
Asenapine
Meclofenamic acid may decrease the antihypertensive activities of Asenapine.
Asian ginseng extract
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ginseng.
Atenolol
Meclofenamic acid may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Meclofenamic acid.
azficel-T
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Meclofenamic acid.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Meclofenamic acid.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Meclofenamic acid.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Meclofenamic acid.
Balsalazide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Balsalazide.
Bazedoxifene
Meclofenamic acid may increase the thrombogenic activities of Bazedoxifene.
Becaplermin
Meclofenamic acid may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Meclofenamic acid.
Benzthiazide
The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Meclofenamic acid.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Meclofenamic acid.
Betamethasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Betamethasone.
Betaxolol
Meclofenamic acid may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Meclofenamic acid.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meclofenamic acid.
Bisoprolol
Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Meclofenamic acid may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Meclofenamic acid may decrease the antihypertensive activities of Bopindolol.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Meclofenamic acid.
Budesonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Meclofenamic acid.
Bupranolol
Meclofenamic acid may decrease the antihypertensive activities of Bupranolol.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Meclofenamic acid.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Meclofenamic acid.
Capsaicin
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Capsaicin.
Captopril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Captopril.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Meclofenamic acid.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Meclofenamic acid.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Meclofenamic acid.
Carteolol
Meclofenamic acid may decrease the antihypertensive activities of Carteolol.
Carvedilol
Meclofenamic acid may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Meclofenamic acid.
Celiprolol
Meclofenamic acid may decrease the antihypertensive activities of Celiprolol.
Certoparin
Meclofenamic acid may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Meclofenamic acid.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Meclofenamic acid.
Chlorotrianisene
Meclofenamic acid may increase the thrombogenic activities of Chlorotrianisene.
Chlorphenesin
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Chlorphenesin.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Meclofenamic acid.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Cilazapril.
Cinoxacin
Meclofenamic acid may increase the neuroexcitatory activities of Cinoxacin.
Ciprofloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Ciprofloxacin.
Cisplatin
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Cisplatin.
Citalopram
Citalopram may increase the antiplatelet activities of Meclofenamic acid.
Citric Acid
Meclofenamic acid may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Meclofenamic acid may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Meclofenamic acid.
Colesevelam
Colesevelam can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Cortisone acetate.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Meclofenamic acid.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Meclofenamic acid.
Cyclosporine
Meclofenamic acid may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Meclofenamic acid may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Meclofenamic acid may increase the anticoagulant activities of Dalteparin.
Danaparoid
Meclofenamic acid may increase the anticoagulant activities of Danaparoid.
Deferasirox
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Deflazacort.
Desipramine
Meclofenamic acid may decrease the antihypertensive activities of Desipramine.
Desirudin
Meclofenamic acid may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desoxycorticosterone Pivalate.
Desvenlafaxine
Desvenlafaxine may increase the antiplatelet activities of Meclofenamic acid.
Dexamethasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Meclofenamic acid.
Dextran
Meclofenamic acid may increase the anticoagulant activities of Dextran.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Meclofenamic acid.
Dicumarol
Meclofenamic acid may increase the anticoagulant activities of Dicoumarol.
Dienestrol
Meclofenamic acid may increase the thrombogenic activities of Dienestrol.
Diethylstilbestrol
Meclofenamic acid may increase the thrombogenic activities of Diethylstilbestrol.
Diflorasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Meclofenamic acid.
Difluprednate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Meclofenamic acid.
Dihydrostreptomycin
Meclofenamic acid may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Meclofenamic acid.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Meclofenamic acid.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Meclofenamic acid.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Meclofenamic acid.
Drospirenone
Meclofenamic acid may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Droxicam.
Duloxetine
Duloxetine may increase the antiplatelet activities of Meclofenamic acid.
Edetic Acid
Meclofenamic acid may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Meclofenamic acid may increase the anticoagulant activities of Edoxaban.
Eicosapentaenoic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Icosapent.
Enalapril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Enalaprilat.
Enoxacin
Meclofenamic acid may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Meclofenamic acid may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Meclofenamic acid may increase the anticoagulant activities of Enoxaparin.
Eplerenone
Meclofenamic acid may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Meclofenamic acid.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Meclofenamic acid.
Equol, (-)-
Meclofenamic acid may increase the thrombogenic activities of Equol.
Escitalopram
Escitalopram may increase the antiplatelet activities of Meclofenamic acid.
Esmolol
Meclofenamic acid may decrease the antihypertensive activities of Esmolol.
Estradiol
Meclofenamic acid may increase the thrombogenic activities of Estradiol.
Estradiol acetate
Meclofenamic acid may increase the thrombogenic activities of Estradiol acetate.
Estradiol Cypionate
Meclofenamic acid may increase the thrombogenic activities of Estradiol cypionate.
Estradiol Valerate
Meclofenamic acid may increase the thrombogenic activities of Estradiol valerate.
Estriol
Meclofenamic acid may increase the thrombogenic activities of Estriol.
Estrogens, Conjugated (USP)
Meclofenamic acid may increase the thrombogenic activities of Conjugated estrogens.
Estrogens, Esterified (USP)
Meclofenamic acid may increase the thrombogenic activities of Estrogens, esterified.
Estrone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Meclofenamic acid.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Meclofenamic acid.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Meclofenamic acid.
Ethinyl Estradiol
Meclofenamic acid may increase the thrombogenic activities of Ethinyl Estradiol.
Ethylenediaminetetraacetate
Meclofenamic acid may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Meclofenamic acid.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Meclofenamic acid.
Etoricoxib
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Etoricoxib.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Meclofenamic acid.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Meclofenamic acid.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Meclofenamic acid.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Meclofenamic acid.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Meclofenamic acid.
Fish Oils
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fish oil.
Fleroxacin
Meclofenamic acid may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Meclofenamic acid.
Fludrocortisone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fludrocortisone.
Fluindione
Meclofenamic acid may increase the anticoagulant activities of Fluindione.
Flumequine
Meclofenamic acid may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluorometholone.
Fluoxetine
Fluoxetine may increase the antiplatelet activities of Meclofenamic acid.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Meclofenamic acid.
Fluticasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluticasone.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluticasone propionate.
Fluvoxamine
Fluvoxamine may increase the antiplatelet activities of Meclofenamic acid.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Meclofenamic acid.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Meclofenamic acid.
Fondaparinux sodium
Meclofenamic acid may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fosinopril.
Framycetin
Meclofenamic acid may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Meclofenamic acid.
Gatifloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Meclofenamic acid may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Meclofenamic acid.
Gemifloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Meclofenamic acid may increase the neuroexcitatory activities of Gemifloxacin.
Genistein
Meclofenamic acid may increase the thrombogenic activities of Genistein.
Gentamicin
Meclofenamic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Ginseng Preparation
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ginseng.
Grepafloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Haloperidol.
Heparin
Meclofenamic acid may increase the anticoagulant activities of Heparin.
Hydralazine
Meclofenamic acid may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meclofenamic acid.
Hydrocortisone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Meclofenamic acid.
Ibandronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Meclofenamic acid.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Meclofenamic acid.
Imidapril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Meclofenamic acid.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Meclofenamic acid.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Meclofenamic acid.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Meclofenamic acid.
Kanamycin
Meclofenamic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Meclofenamic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Meclofenamic acid.
Ketoprofen
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Meclofenamic acid.
Korean ginseng preparation
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ginseng.
KOREAN GINSENG ROOT
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ginseng.
Korean Ginseng Root Extract
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ginseng.
Labetalol
Meclofenamic acid may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Meclofenamic acid.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Meclofenamic acid.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Meclofenamic acid.
Lepirudin
Meclofenamic acid may increase the anticoagulant activities of Lepirudin.
Levobetaxolol
Meclofenamic acid may decrease the antihypertensive activities of Levobetaxolol.
Levobunolol
Meclofenamic acid may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Meclofenamic acid may increase the neuroexcitatory activities of Levofloxacin.
Levomilnacipran
Levomilnacipran may increase the antiplatelet activities of Meclofenamic acid.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Meclofenamic acid.
Lisinopril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Meclofenamic acid.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Meclofenamic acid.
Lomefloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Lomefloxacin.
Lornoxicam
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Lornoxicam.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Meclofenamic acid.
Loteprednol
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Loteprednol.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Meclofenamic acid.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Meclofenamic acid.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Magnesium salicylate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Meclofenamic acid.
Medronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Meclofenamic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Meclofenamic acid.
Mepindolol
Meclofenamic acid may decrease the antihypertensive activities of Mepindolol.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Meclofenamic acid.
Mestranol
Meclofenamic acid may increase the thrombogenic activities of Mestranol.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Meclofenamic acid.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Meclofenamic acid.
Methylprednisolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Methylprednisolone.
Metipranolol
Meclofenamic acid may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Meclofenamic acid.
Metoprolol
Meclofenamic acid may decrease the antihypertensive activities of Metoprolol.
Milnacipran
Milnacipran may increase the antiplatelet activities of Meclofenamic acid.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Meclofenamic acid.
Moexipril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Meclofenamic acid.
Moxifloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Moxifloxacin.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Meclofenamic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Meclofenamic acid.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Meclofenamic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Meclofenamic acid.
Nadolol
Meclofenamic acid may decrease the antihypertensive activities of Nadolol.
Nadroparin
Meclofenamic acid may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Meclofenamic acid.
Nalidixic Acid
Meclofenamic acid may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Meclofenamic acid.
Nebivolol
Meclofenamic acid may decrease the antihypertensive activities of Nebivolol.
Nefazodone
Nefazodone may increase the antiplatelet activities of Meclofenamic acid.
Neomycin
Meclofenamic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Meclofenamic acid.
Netilmicin
Meclofenamic acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Niflumic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Niflumic Acid.
Nimesulide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Nimesulide.
Norfloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Meclofenamic acid.
Ofloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Ofloxacin.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Meclofenamic acid.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Meclofenamic acid.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Meclofenamic acid.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Omacetaxine mepesuccinate.
Oxaprozin
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Oxaprozin.
Oxprenolol
Meclofenamic acid may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Meclofenamic acid.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Meclofenamic acid.
Pamidronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Parecoxib.
Paromomycin
Meclofenamic acid may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Paroxetine
Paroxetine may increase the antiplatelet activities of Meclofenamic acid.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Meclofenamic acid.
Pefloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Meclofenamic acid may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Meclofenamic acid may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Meclofenamic acid may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Perindopril.
Phenindione
Meclofenamic acid may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Meclofenamic acid may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Meclofenamic acid.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Meclofenamic acid.
Pindolol
Meclofenamic acid may decrease the antihypertensive activities of Pindolol.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Meclofenamic acid.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Meclofenamic acid.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Meclofenamic acid.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Meclofenamic acid.
Plazomicin
Meclofenamic acid may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Polyestradiol Phosphate
Meclofenamic acid may increase the thrombogenic activities of Polyestradiol phosphate.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Meclofenamic acid.
Pomalidomide
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Pomalidomide.
Potassium Citrate
Meclofenamic acid may increase the anticoagulant activities of Potassium Citrate.
Practolol
Meclofenamic acid may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Meclofenamic acid.
Prasterone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Pregnenolone.
Probenecid
The serum concentration of Meclofenamic acid can be increased when it is combined with Probenecid.
Promestriene
Meclofenamic acid may increase the thrombogenic activities of Promestriene.
Propafenone
Meclofenamic acid may decrease the antihypertensive activities of Propafenone.
Propranolol
Meclofenamic acid may decrease the antihypertensive activities of Propranolol.
protein C, human
Meclofenamic acid may increase the anticoagulant activities of Protein C.
protein S, human
Meclofenamic acid may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Meclofenamic acid may increase the anticoagulant activities of Protocatechualdehyde.
Quinapril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Quinapril.
Quinestrol
Meclofenamic acid may increase the thrombogenic activities of Quinestrol.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Meclofenamic acid.
Ramipril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Resveratrol.
Reviparin
Meclofenamic acid may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Meclofenamic acid may increase the anticoagulant activities of Reviparin.
Rimexolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Risedronate.
Rivaroxaban
Meclofenamic acid may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Meclofenamic acid.
Rosoxacin
Meclofenamic acid may increase the neuroexcitatory activities of Rosoxacin.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Meclofenamic acid.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Meclofenamic acid.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Meclofenamic acid.
Salsalate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Meclofenamic acid.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Meclofenamic acid.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Meclofenamic acid.
Sertraline
Sertraline may increase the antiplatelet activities of Meclofenamic acid.
Sisomicin
Meclofenamic acid may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Citrate
Meclofenamic acid may increase the anticoagulant activities of Sodium Citrate.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Meclofenamic acid.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Meclofenamic acid.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Meclofenamic acid.
Sotalol
Meclofenamic acid may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Sparfloxacin.
Spirapril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Spirapril.
Spironolactone
Meclofenamic acid may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Meclofenamic acid may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Meclofenamic acid.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Meclofenamic acid.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Meclofenamic acid.
synthetic conjugated estrogens, A
Meclofenamic acid may increase the thrombogenic activities of Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
Meclofenamic acid may increase the thrombogenic activities of Synthetic Conjugated Estrogens, B.
Tacrolimus
Meclofenamic acid may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Meclofenamic acid.
Talinolol
Meclofenamic acid may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Meclofenamic acid.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Meclofenamic acid.
Temafloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Meclofenamic acid.
Terbutaline
Meclofenamic acid may decrease the antihypertensive activities of Terbutaline.
Terbutaline Sulfate
Meclofenamic acid may decrease the antihypertensive activities of Terbutaline.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Meclofenamic acid.
Tertatolol
Meclofenamic acid may decrease the antihypertensive activities of Tertatolol.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Tiaprofenic acid.
Tibolone
Meclofenamic acid may increase the thrombogenic activities of Tibolone.
Tiludronate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Tiludronic acid.
Timolol
Meclofenamic acid may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Meclofenamic acid may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Tixocortol.
Tobramycin
Meclofenamic acid may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Meclofenamic acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Meclofenamic acid.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Meclofenamic acid.
Trandolapril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Meclofenamic acid.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Meclofenamic acid.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Meclofenamic acid.
Triamcinolone
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Triamcinolone.
Triamterene
Meclofenamic acid may decrease the antihypertensive activities of Triamterene.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Meclofenamic acid.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Meclofenamic acid.
Trisodium Citrate Anhydrous
Meclofenamic acid may increase the anticoagulant activities of Sodium Citrate.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Trolamine salicylate.
Trovafloxacin
Meclofenamic acid may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Meclofenamic acid may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Meclofenamic acid.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Meclofenamic acid.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Meclofenamic acid.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Meclofenamic acid.
Venlafaxine
Venlafaxine may increase the antiplatelet activities of Meclofenamic acid.
Warfarin
Meclofenamic acid may increase the anticoagulant activities of Warfarin.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Meclofenamic acid.
Zofenopril
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Meclofenamic acid.
